Toronto General Research Institute (TGRI) is a leader in innovative biomedical research: its researchers discovered insulin, created the first cardiac pacemaker and developed new lung repair techniques, among many other novel approaches. TGRI is the research arm of Toronto General Hospital and focuses on multidisciplinary research that reflects and supports the medical programs of the hospital. Research areas include cardiovascular disease, transplantation, regenerative medicine, diabetes, infectious diseases, autoimmunity disorders, psychosocial care and health systems. TGRI research laboratories and facilities are primarily located at Toronto General Hospital, the Max Bell Research Centre and the MaRS Centre.
TGRI researchers are grouped into the following Divisions based on their research program:
- Advanced Diagnostics
- Experimental Therapeutics
- Support, Systems & Outcomes